Tag: research grade proteins market research

Claim 20% Off Global Market Reports With Code ONLINE20 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

What Is The Predicted Market Size Of The Research-Grade Proteins Industry By 2029?

In recent times, there has been a massive expansion in the market size of research-grade proteins. The market size, which was at $1.11 billion in 2024, is projected to grow up to $1.33 billion in 2025, reflecting a compound annual growth rate (CAGR) of 20.4%. The significant upsurge in the previous period is a direct result of numerous influencing factors such as enhanced research activities, a surge in R&D operations in the pharmaceutical and biotech sectors, the escalating demand for personalized treatments, increased financial support from government bodies and educational institutions, and strategic acquisitions and collaborations.

In forthcoming years, the market for research-grade proteins is anticipated to expand at a brisk pace, reaching a valuation of $2.74 billion in 2029 with a Compound Annual Growth Rate (CAGR) of 19.7%. This predicted growth trend over the forecast period is linked to factors such as the advancement in proteomics research, an increasing number of clinical trials, the incorporation of AI and data analytics, industrial applications of research-grade proteins, and a surge in demand for sophisticated research tools. The forecast period is also expected to witness key trends like increasing cognizance about groundbreaking technologies, forward strides in the biotechnology field, progress in proteomics and genomics, broadening applications in drug development, and evolved research tools’ use in biotechnology and pharmaceutical sectors.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15917&type=smp

Which Growth Drivers Are Shaping The Research-Grade Proteins Market Outlook?

The escalating count of clinical trials is projected to fuel the expansion of the research-grade proteins market. Clinical trials imply research studies that explore the efficacy and safety of new therapeutic interventions, medical devices, or treatments in human subjects. There’s a surge in the count of clinical trials owing to advancements in medical research, industry investment, regulatory amendments, the burden of disease, and patient demand. Research-grade proteins play a pivotal role in clinical trials as they are indispensable for tasks such as biomarker development, quality control, drug target identification, assay development, and establishing reference standards, thereby guaranteeing the reliability and precision of experimental results. For example, data from ClinicalTrials.gov, a US-based clinical trial database, indicates that by the cessation of 2023, the number of registered clinical trials worldwide on ClinicalTrials.gov had surged to 477,234, signifying an increase from 437,512 recorded trials in 2022. Consequently, the escalation in the number of clinical trials is stoking the growth of the research-grade proteins market.

How Does The Research-Grade Proteins Market Differ By Segment?

The research-grade proteins market covered in this report is segmented –

1) By Product: Cytokines And Growth Factors, Antibodies, Immune Checkpoint Proteins, Virus Antigens, Enzymes, Recombinant Regulatory Proteins, Hormones, Other Products

2) By Host Cell: Mammalian Cells, Bacterial Cells, Fungi And Yeast, Insect Cells, Other Host Cells

3) By End-Use: Pharmaceutical And Biotechnology Companies, Academic And Research Institute, Other End-Uses

Subsegments:

1) By Cytokines And Growth Factors: Interleukins, Interferons, Colony Stimulating Factors, Erythropoietin, Granulocyte Macrophage Colony-Stimulating Factor

2) By Antibodies: Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies, Conjugated Antibodies

3) By Immune Checkpoint Proteins: PD-1 Inhibitors, PD-L1 Inhibitors, CTLA-4 Inhibitors

4) By Virus Antigens: HIV Antigens, Hepatitis Antigens, Influenza Antigens, Hepatitis B Antigens

5) By Enzymes: Restriction Enzymes, Proteases, Ligases, Kinases

6) By Recombinant Regulatory Proteins: Transcription Factors, Regulatory Enzymes, Epigenetic Modifiers

7) By Hormones: Insulin, Thyroid Hormones, Growth Hormones, Adrenaline

8) By Other Products: Peptides, Serum Proteins, Antigen-Binding Proteins

What New Opportunities Are Emerging From Trends In The Research-Grade Proteins Market?

Major firms in the research-grade proteins sector are creating Cas9 proteins to increase their effectiveness and usefulness in genome editing and various biotech applications. Cas9 proteins assist genome editing by functioning as molecular scissors capable of slicing DNA at specific points specified by a guide RNA (gRNA). For instance, Thermo Fisher Scientific Inc., a prominent biotechnology firm based in the USA, launched a state-of-the-art GMP-manufactured Gibco CTS TrueCut Cas9 Protein in April 2022. This superior, clinically compliant Cas9 protein is produced under the strict guidelines of Good Manufacturing Practice (GMP). This product is specifically manufactured for genome editing applications, ensuring optimal purity and performance for precise CRISPR-based research thus enabling progress in genetic engineering and treatment development.

Which Firms Are Making The Biggest Impact In The Research-Grade Proteins Market?

Major companies operating in the research-grade proteins market are Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Bio-Techne, Stemcell Technologies Inc., Miltenyi Biotec, GenScript Biotech Corporation, Sino Biological Inc., ACROBiosystems, OriGene Technologies Inc., RayBiotech Inc., Rockland Immunochemicals Inc., Proteintech Group Inc., Novus Biologicals LLC, Active Motif, Aviva Systems Biology Corporation, StressMarq Biosciences Inc., Abnova Corporation, AnaSpec, Biomatik, Prospec-Tany Technogene Ltd., Cusabio Technology LLC, United States Biological, Laurus Bio, Boster Biological Technology, AMS Biotechnology Europe Ltd (AMSBIO)

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/research-grade-proteins-global-market-report

Which Region Is Leading Innovation In The Research-Grade Proteins Market?

North America was the largest region in the research-grade proteins market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the research-grade proteins market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=15917&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What CAGR Is Anticipated for the Branded Generics Market Through 2029?

The market size for research-grade proteins has seen an exceptional surge over the past few years. The market will move from a value of $1.11 billion in 2024, escalating to $1.33 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 20.4%. The upward trend during the historical period can be sourced back to factors such as the rising number of research studies, increased research and development undertakings in the pharmaceutical and biotechnology fields, increasing demand for tailor-made medicine, elevated investments by governmental bodies and sundry academic institutions, and the strategic mergers and associations.

The market size of research-grade proteins is anticipated to experience a swift expansion over the next few years. The anticipated growth will reach “$2.74 billion in 2029 with a compound annual growth rate (CAGR) of 19.7%. The predicted growth during the forecast period is credited to advancements in proteomics research, an increasing number of clinical trials, integration of artificial intelligence and data analytics, application of research-grade proteins in industrial usage, and escalating demand for cutting-edge research tools. Key trends during the forecast period will be the rising awareness of innovative technologies, advancing techniques in the biotechnology industry, developments in proteomics and genomics, widening applications in drug development, and sophisticated research tools in biotechnology and pharmaceutical sectors.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15917&type=smp

What Market Forces Are Driving The Branded Generics Sector In 2025 And Beyond?

The rising incidence of chronic diseases are projected to fuel the expansion of the branded generics market. Chronic diseases, often incurable yet manageable, are persistent in nature. Increasing tobacco consumption, inadequate nutrition, lack of physical activity, and excessive alcohol intake are some factors contributing to the rise of chronic diseases. Globally, consumers prefer branded generics for treating chronic diseases due to their lower price compared to conventional medications. For example, in September 2022, the World Health Organization (WHO) 2022 Highlights reported that 74% of all deaths worldwide, equating to 41 million fatalities, resulted from noncommunicable diseases (NCDs) or chronic diseases. This upsurge in chronic diseases is anticipated to drive the demand for branded generics in the forecast period.

The research-grade proteins market covered in this report is segmented –

1) By Product: Cytokines And Growth Factors, Antibodies, Immune Checkpoint Proteins, Virus Antigens, Enzymes, Recombinant Regulatory Proteins, Hormones, Other Products

2) By Host Cell: Mammalian Cells, Bacterial Cells, Fungi And Yeast, Insect Cells, Other Host Cells

3) By End-Use: Pharmaceutical And Biotechnology Companies, Academic And Research Institute, Other End-Uses

Subsegments:

1) By Cytokines And Growth Factors: Interleukins, Interferons, Colony Stimulating Factors, Erythropoietin, Granulocyte Macrophage Colony-Stimulating Factor

2) By Antibodies: Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies, Conjugated Antibodies

3) By Immune Checkpoint Proteins: PD-1 Inhibitors, PD-L1 Inhibitors, CTLA-4 Inhibitors

4) By Virus Antigens: HIV Antigens, Hepatitis Antigens, Influenza Antigens, Hepatitis B Antigens

5) By Enzymes: Restriction Enzymes, Proteases, Ligases, Kinases

6) By Recombinant Regulatory Proteins: Transcription Factors, Regulatory Enzymes, Epigenetic Modifiers

7) By Hormones: Insulin, Thyroid Hormones, Growth Hormones, Adrenaline

8) By Other Products: Peptides, Serum Proteins, Antigen-Binding Proteins

What Long-Term Trends Are Likely To Affect The Branded Generics Market?

Leading enterprises in the market for research-grade proteins are working on the creation of Cas9 proteins, with an aim to boost their functionality and usefulness in genome editing and other biotech applications. Cas9 proteins contribute to genome editing by functioning as molecular scissors that can sever DNA at specific points determined by a guide RNA (gRNA). For instance, Thermo Fisher Scientific Inc., a biotechnology firm based in the US, launched an inventive GMP-manufactured Gibco CTS TrueCut Cas9 Protein in April 2022. This high-quality Cas9 protein, compliant with clinical standards and produced under Good Manufacturing Practice (GMP) conditions, is intended for genome editing applications. It offers superior purity and functionality specifically designed for precise CRISPR-based research, thus aiding progress in genetic engineering and therapeutic development.

Which Firms Are Considered Leaders In The Branded Generics Market Space?

Major companies operating in the research-grade proteins market are Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Bio-Techne, Stemcell Technologies Inc., Miltenyi Biotec, GenScript Biotech Corporation, Sino Biological Inc., ACROBiosystems, OriGene Technologies Inc., RayBiotech Inc., Rockland Immunochemicals Inc., Proteintech Group Inc., Novus Biologicals LLC, Active Motif, Aviva Systems Biology Corporation, StressMarq Biosciences Inc., Abnova Corporation, AnaSpec, Biomatik, Prospec-Tany Technogene Ltd., Cusabio Technology LLC, United States Biological, Laurus Bio, Boster Biological Technology, AMS Biotechnology Europe Ltd (AMSBIO)

https://www.thebusinessresearchcompany.com/report/research-grade-proteins-global-market-report

What Role Do Regional Policies And Investments Play In Branded Generics Market Expansion?

North America was the largest region in the research-grade proteins market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the research-grade proteins market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=15917&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Key Projections for the CAGR of the Research-Grade Proteins Market Size From 2025 to 2034?

Over recent years, the market size for research-grade proteins has witnessed substantial growth. The market is projected to expand from a valuation of $1.11 billion in 2024 to $1.33 billion in 2025, marking a compound annual growth rate (CAGR) of 20.4%. Various factors have contributed to this growth over the historic period, including a surge in research activities, an escalation in R&D initiatives within the pharmaceutical and biotechnology sectors, a growing demand for personalized medicine, increased governmental and academic investment, and strategic acquisitions and partnerships.

The market size for research-grade proteins is predicted to witness substantial growth in the upcoming years, expanding to $2.74 billion by 2029 with a CAGR of 19.7%. The development during the forecasted period is largely due to the progress in proteomics research, the increasing number of clinical trials, the melding of AI and data analytics, the application of research-grade proteins in industrial settings, and the escalated demand for sophisticated research tools. Key trends for this period encompass a heightened awareness of emergent technologies, technological breakthroughs in the biotechnology sector, progression in proteomics and genomics, broadening uses in drug development, and upgraded research equipment in the biotechnology and pharmaceutical arenas.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15917&type=smp

How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theResearch-Grade Proteins Market?

The escalating count of clinical trials is predicted to stimulate the expansion of the research-grade proteins market. Clinical trials are research studies that examine the safety and efficacy of new medical treatments, interventions, or devices in humans. The increasing number of clinical trials can be attributed to developments in medical research, disease prevalence, regulatory modifications, patient demand, and industry investment. In clinical trials, research-grade proteins play a vital role as they serve as indispensable instruments for biomarker development, assay development, drug target identification, quality control, and reference standards, assuring the precision and dependability of experimental data. For example, as per ClinicalTrials.gov, a clinical trial registry based in the US, by the end of 2023, 477,234 clinical trials were recorded globally, which indicates a rise compared to 437,512 clinical trials registered in 2022. Consequently, the escalating count of clinical trials is steering the expansion of the research-grade proteins market.

Which Segments in the Research-Grade Proteins Offer the Most Growth?

The research-grade proteins market covered in this report is segmented –

1) By Product: Cytokines And Growth Factors, Antibodies, Immune Checkpoint Proteins, Virus Antigens, Enzymes, Recombinant Regulatory Proteins, Hormones, Other Products

2) By Host Cell: Mammalian Cells, Bacterial Cells, Fungi And Yeast, Insect Cells, Other Host Cells

3) By End-Use: Pharmaceutical And Biotechnology Companies, Academic And Research Institute, Other End-Uses

Subsegments:

1) By Cytokines And Growth Factors: Interleukins, Interferons, Colony Stimulating Factors, Erythropoietin, Granulocyte Macrophage Colony-Stimulating Factor

2) By Antibodies: Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies, Conjugated Antibodies

3) By Immune Checkpoint Proteins: PD-1 Inhibitors, PD-L1 Inhibitors, CTLA-4 Inhibitors

4) By Virus Antigens: HIV Antigens, Hepatitis Antigens, Influenza Antigens, Hepatitis B Antigens

5) By Enzymes: Restriction Enzymes, Proteases, Ligases, Kinases

6) By Recombinant Regulatory Proteins: Transcription Factors, Regulatory Enzymes, Epigenetic Modifiers

7) By Hormones: Insulin, Thyroid Hormones, Growth Hormones, Adrenaline

8) By Other Products: Peptides, Serum Proteins, Antigen-Binding Proteins

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=15917&type=smp

What Are the Fastest-Growing Geographies in the #How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theResearch-Grade Proteins Market?# Market?

North America was the largest region in the research-grade proteins market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the research-grade proteins market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

What Are the Current Market Growth and Trends in the Research-Grade Proteins Industry?

Leading corporations in the research-grade proteins industry are seeking to enhance the functionality and usability of Cas9 proteins in genome editing and other biotech applications. Cas9 proteins facilitate genome modification by working as molecular shears, accurately cutting DNA at guide RNA (gRNA) specified points. In a concrete example, US biotechnology firm Thermo Fisher Scientific Inc. introduced an advanced GMP-manufactured Gibco CTS TrueCut Cas9 Protein in April 2022. This high-quality, clinically compliant Cas9 protein is produced under Good Manufacturing Practice (GMP) regulations. It is purpose-built for genome editing uses, offering optimal purity and function specifically designed for precision-focused CRISPR-based study, promoting progress in genetic engineering and therapeutic research.

View the full report here:

https://www.thebusinessresearchcompany.com/report/research-grade-proteins-global-market-report

What Are the Key Elements That Define the Research-Grade Proteins Market?

Research-grade proteins refer to proteins that are produced and purified to a high standard of quality and purity for use in scientific research. These proteins are utilized in various experimental and analytical applications, including studies in molecular biology, biochemistry, cell biology, and drug development. They are essential tools for understanding protein function, interaction, structure, and for developing new therapeutic approaches.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15917

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#How Has the Research-Grade Proteins Market Growth Performance Trended Historically, And What Lies Ahead?_x000D_

The market size for research-grade proteins has seen a dramatic expansion recently. It is projected to rise from $1.11 billion in 2024 to $1.35 billion in 2025, with a compound annual growth rate (CAGR) of 21.4%. The surge in this period can be ascribed to a rise in research activities, an increase in research and development undertakings in pharmaceutical and biotechnology sectors, a growing preference for personalized medicine, amplified investments from government bodies and various academic institutions, and strategic partnerships and acquisitions._x000D_

_x000D_

#What Is the Forecast for the Research-Grade Proteins Market Size Through 2029?#_x000D_

Expectations are high for substantial expansion in the research-grade proteins market within the coming years. By 2029, the market is projected to reach a value of $2.9 billion, boasting a compound annual growth rate (CAGR) of 21.2%. Factors contributing to this predicted growth during the forecast period include advances in proteomics research, an increasing number of clinical trials, the incorporation of AI and data analytics, usage of research-grade proteins in industrial applications, and a surging demand for sophisticated research instruments. The projection period will likely also see burgeoning awareness of novel technologies, technological progress in the biotech sector, advancements in the realms of proteomics and genomics, broader applications in drug development, and the evolution of research tools within the biotechnology and pharmaceutical fields._x000D_

_x000D_

#Download The Free Sample Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=15917&type=smp_x000D_

_x000D_

#What are the Key Market Players in Research-Grade Proteins Market and How They’re Evolving?#_x000D_

Major companies operating in the research-grade proteins market are Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Bio-Techne, Stemcell Technologies Inc., Miltenyi Biotec, GenScript Biotech Corporation, Sino Biological Inc., ACROBiosystems, OriGene Technologies Inc., RayBiotech Inc., Rockland Immunochemicals Inc., Proteintech Group Inc., Novus Biologicals LLC, Active Motif, Aviva Systems Biology Corporation, StressMarq Biosciences Inc., Abnova Corporation, AnaSpec, Biomatik, Prospec-Tany Technogene Ltd., Cusabio Technology LLC, United States Biological, Laurus Bio, Boster Biological Technology, AMS Biotechnology Europe Ltd (AMSBIO)_x000D_

_x000D_

#What Are the Primary Growth Drivers in the Research-Grade Proteins Market?#_x000D_

The surge in clinical trials is anticipated to spur the expansion of the research-grade proteins market. Clinical trials, which are research studies that evaluate the safety and efficacy of new medical interventions or equipment in humans, are on the rise. This increase can be attributed to advancements in medical research, changes in regulations, patient need, industry investments, and disease prevalence. Research-grade proteins contribute significantly to clinical trials as they are crucial for developing biomarkers, developing assays, identifying drug targets, maintaining quality control, and establishing reference standards, all of which ensure the precision and trustworthiness of research data. For example, as per ClinicalTrials.gov, a clinical trial registry based in the US, there were 477,234 clinical trials registered worldwide on ClinicalTrials.gov by the end of 2023, a significant rise from the 437,512 trials registered in 2022. Consequently, the escalating number of clinical trials is fueling the expansion of the research-grade proteins market._x000D_

_x000D_

#Request For A Customized Report:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=15917&type=smp_x000D_

_x000D_

#What Are the Leading Segments in the Global Research-Grade Proteins Industry?#_x000D_

The research-grade proteins market covered in this report is segmented –_x000D_

_x000D_

1) By Product: Cytokines And Growth Factors, Antibodies, Immune Checkpoint Proteins, Virus Antigens, Enzymes, Recombinant Regulatory Proteins, Hormones, Other Products_x000D_

2) By Host Cell: Mammalian Cells, Bacterial Cells, Fungi And Yeast, Insect Cells, Other Host Cells_x000D_

3) By End-Use: Pharmaceutical And Biotechnology Companies, Academic And Research Institute, Other End-Uses_x000D_

_x000D_

Subsegments:_x000D_

1) By Cytokines And Growth Factors: Interleukins, Interferons, Colony Stimulating Factors, Erythropoietin, Granulocyte Macrophage Colony-Stimulating Factor_x000D_

2) By Antibodies: Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies, Conjugated Antibodies_x000D_

3) By Immune Checkpoint Proteins: PD-1 Inhibitors, PD-L1 Inhibitors, CTLA-4 Inhibitors_x000D_

4) By Virus Antigens: HIV Antigens, Hepatitis Antigens, Influenza Antigens, Hepatitis B Antigens_x000D_

5) By Enzymes: Restriction Enzymes, Proteases, Ligases, Kinases_x000D_

6) By Recombinant Regulatory Proteins: Transcription Factors, Regulatory Enzymes, Epigenetic Modifiers_x000D_

7) By Hormones: Insulin, Thyroid Hormones, Growth Hormones, Adrenaline_x000D_

8) By Other Products: Peptides, Serum Proteins, Antigen-Binding Proteins_x000D_

_x000D_

#What Are the Key Market Trends in the Research-Grade Proteins Industry?#_x000D_

Leading firms in the research-grade proteins market are innovating Cas9 proteins to improve its efficiency and usability in genome modification and other bio-technical uses. These Cas9 proteins function as molecular cutters, enabling genome editing by cutting DNA at specified sites, guided by a guide RNA (gRNA). For example, in April 2022, Thermo Fisher Scientific Inc., an American biotech firm, launched a groundbreaking GMP-manufactured Gibco CTS TrueCut Cas9 Protein. This high-quality Cas9 protein, created in accordance with Good Manufacturing Practice (GMP) conditions, is specifically formulated for genome editing purposes. It offers high precision and functionality, designed to support precise CRISPR-based research and consequently aid in the progression of genetic engineering and therapy development._x000D_

_x000D_

#Access The Full Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/report/research-grade-proteins-global-market-report_x000D_

_x000D_

#What Is the Regional Outlook for the Research-Grade Proteins Market?#_x000D_

North America was the largest region in the research-grade proteins market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the research-grade proteins market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa._x000D_

_x000D_

#Purchase The Full Report Today:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15917_x000D_

_x000D_

#This Report Delivers Insight On: #_x000D_

1. How big is the research-grade proteins market, and how is it changing globally?_x000D_

2. Who are the major companies in the research-grade proteins market, and how are they performing?_x000D_

3. What are the key opportunities and risks in the research-grade proteins market right now?_x000D_

4. Which products or customer segments are growing the most in the research-grade proteins market?_x000D_

5. What factors are helping or slowing down the growth of the research-grade proteins market?_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Asia +44 2071930708_x000D_

Europe +44 7882 955267_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the research-grade proteins industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

How Fast Is The Research-Grade Proteins Market Expected to Grow Between 2025 And 2029?

In recent times, there has been notable exponential growth in the size of the research-grade proteins market. The market, which stood at $1.11 billion in 2024, is projected to reach $1.35 billion in 2025. This indicates a compound annual growth rate (CAGR) of 21.4%. The historic period’s growth is attributed to factors such as enhanced research activities, a rise in research and development initiatives within the pharmaceutical and biotech industry, burgeoning demand for personalised medicine, increased investment by government bodies and academic institutions, as well as strategic collaborations and acquisitions.

The market size for research-grade proteins is predicted to witness a considerable expansion in the upcoming years, reaching $2.9 billion by 2029 with a CAGR of 21.2%. This projected growth in the forecast period can be ascribed to developments in proteomics research, increasing clinical trials, the integration of AI and data analytics, the utilisation of research-grade proteins in industrial settings, and the escalated demand for sophisticated research tools. Key trends during the forecast period are expected to include rising awareness about innovative technologies, technological progress in the biotech sector, advances in proteomics and genomics, broadening applications in drug formulation, and improved research utilities in biotechnological and pharmaceutical sectors.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15917&type=smp

Which Primay Drivers Are Accelerating Growth in the Research-Grade Proteins Market?

The rise in clinical trials is anticipated to boost the expansion of the research-grade proteins market. Clinical trials, which are research studies evaluating the safety and effectiveness of new medical treatments, interventions, or instruments in humans, are increasing due to progress in medical research, disease prevalence, regulatory shifts, consumer demand and industrial investment. Research-grade proteins contribute significantly to clinical trials, acting as critical tools for biomarker development, assay development, drug target identification, quality control, and reference standards, which guarantee the precision and dependability of experimental data. For example, according to ClinicalTrials.gov, a clinical trial registry based in the US, there were 477,234 global registrations of clinical trials by the end of 2023, a rise when compared to 437,512 clinical trials registered in 2022. Therefore, the escalating number of clinical trials fuels the expansion of the research-grade proteins market.

What Segment Types Define the Research-Grade Proteins Market Structure?

The research-grade proteins market covered in this report is segmented –

1) By Product: Cytokines And Growth Factors, Antibodies, Immune Checkpoint Proteins, Virus Antigens, Enzymes, Recombinant Regulatory Proteins, Hormones, Other Products

2) By Host Cell: Mammalian Cells, Bacterial Cells, Fungi And Yeast, Insect Cells, Other Host Cells

3) By End-Use: Pharmaceutical And Biotechnology Companies, Academic And Research Institute, Other End-Uses

Subsegments:

1) By Cytokines And Growth Factors: Interleukins, Interferons, Colony Stimulating Factors, Erythropoietin, Granulocyte Macrophage Colony-Stimulating Factor

2) By Antibodies: Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies, Conjugated Antibodies

3) By Immune Checkpoint Proteins: PD-1 Inhibitors, PD-L1 Inhibitors, CTLA-4 Inhibitors

4) By Virus Antigens: HIV Antigens, Hepatitis Antigens, Influenza Antigens, Hepatitis B Antigens

5) By Enzymes: Restriction Enzymes, Proteases, Ligases, Kinases

6) By Recombinant Regulatory Proteins: Transcription Factors, Regulatory Enzymes, Epigenetic Modifiers

7) By Hormones: Insulin, Thyroid Hormones, Growth Hormones, Adrenaline

8) By Other Products: Peptides, Serum Proteins, Antigen-Binding Proteins

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=15917&type=smp

Which Regions Are Key Players in the Growth of the Research-Grade Proteins Market?

North America was the largest region in the research-grade proteins market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the research-grade proteins market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

What Are the Key Market Trends in the Research-Grade Proteins Market Over the Coming Years?

Key players in the research-grade proteins market are pushing boundaries by developing Cas9 proteins; these help enhance functionality and applicability specifically in genome editing and biotechnological applications. Functioning as molecular scissors, the Cas9 proteins are capable of precisely cutting DNA at specific locations determined by guide RNA (gRNA). An example of this advancement was showcased in April 2022, when Thermo Fisher Scientific Inc., a biotechnology company based in the US, launched a state-of-the-art GMP-manufactured Gibco CTS TrueCut Cas9 Protein. This product, produced under stringent Good Manufacturing Practice (GMP) conditions, was engineered for genome editing applications. It offers high purity and functionality specifically crafted for accurate CRISPR-based research, which supports progress in genetic engineering and the development of therapeutics.

View the full report here:

https://www.thebusinessresearchcompany.com/report/research-grade-proteins-global-market-report

What Is the Definition of the Research-Grade Proteins Market?

Research-grade proteins refer to proteins that are produced and purified to a high standard of quality and purity for use in scientific research. These proteins are utilized in various experimental and analytical applications, including studies in molecular biology, biochemistry, cell biology, and drug development. They are essential tools for understanding protein function, interaction, structure, and for developing new therapeutic approaches.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15917

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Are the Primary Drivers Supporting the Market Growth of theResearch-Grade Proteins Market?

A rise in clinical trials is supporting the research-grade proteins market. These proteins play a crucial role in drug development through biomarker and assay applications. ClinicalTrials.gov reported 477,234 registered trials globally by the end of 2023, up from 437,512 in 2022. This increase is contributing to the research-grade proteins market’s growth.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15917&type=smp

How Has the Research-Grade Proteins Market Evolved in Recent Years, and What are the Growth Projections for the Forecast Period?

The research-grade proteins market size is projected to grow from $1.11 billion in 2024 to $1.35 billion in 2025, with a CAGR of 21.4%. Growth is attributed to an increase in research activities, growing R&D investments in the pharmaceutical and biotechnology industries, demand for personalized medicine, rising investments from governments and academic institutions, and strategic acquisitions and collaborations.

The research-grade proteins market is anticipated to grow to $2.9 billion in 2029, at a CAGR of 21.2%. This growth is attributed to advancements in proteomics research, the rising number of clinical trials, the integration of AI and data analytics, the use of research-grade proteins in industrial applications, and growing demand for advanced research tools. Key trends include the expansion of biotechnology applications, advancements in proteomics and genomics, and the growing role of these proteins in drug development.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15917

What Are the Latest Innovations Influencing theResearch-Grade Proteins Market?

Companies in the research-grade proteins market are developing advanced Cas9 proteins for genome editing. In April 2022, Thermo Fisher Scientific introduced the GMP-manufactured Gibco CTS TrueCut Cas9 Protein, designed for genome editing applications, offering high purity and functionality for precise CRISPR-based research and therapeutic developments.

Who Are the Major Industry Players Accelerating Growth in theResearch-Grade Proteins Market?

Major companies operating in the research-grade proteins market are Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Bio-Techne, Stemcell Technologies Inc., Miltenyi Biotec, GenScript Biotech Corporation, Sino Biological Inc., ACROBiosystems, OriGene Technologies Inc., RayBiotech Inc., Rockland Immunochemicals Inc., Proteintech Group Inc., Novus Biologicals LLC, Active Motif, Aviva Systems Biology Corporation, StressMarq Biosciences Inc., Abnova Corporation, AnaSpec, Biomatik, Prospec-Tany Technogene Ltd., Cusabio Technology LLC, United States Biological, Laurus Bio, Boster Biological Technology, AMS Biotechnology Europe Ltd (AMSBIO)

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/research-grade-proteins-global-market-report

Which Primary Segments of the Research-Grade Proteins Market Are Driving Growth and Industry Transformations?

The research-grade proteins market covered in this report is segmented –

1) By Product: Cytokines And Growth Factors, Antibodies, Immune Checkpoint Proteins, Virus Antigens, Enzymes, Recombinant Regulatory Proteins, Hormones, Other Products

2) By Host Cell: Mammalian Cells, Bacterial Cells, Fungi And Yeast, Insect Cells, Other Host Cells

3) By End-Use: Pharmaceutical And Biotechnology Companies, Academic And Research Institute, Other End-Uses

Subsegments:

1) By Cytokines And Growth Factors: Interleukins, Interferons, Colony Stimulating Factors, Erythropoietin, Granulocyte Macrophage Colony-Stimulating Factor

2) By Antibodies: Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies, Conjugated Antibodies

3) By Immune Checkpoint Proteins: PD-1 Inhibitors, PD-L1 Inhibitors, CTLA-4 Inhibitors

4) By Virus Antigens: HIV Antigens, Hepatitis Antigens, Influenza Antigens, Hepatitis B Antigens

5) By Enzymes: Restriction Enzymes, Proteases, Ligases, Kinases

6) By Recombinant Regulatory Proteins: Transcription Factors, Regulatory Enzymes, Epigenetic Modifiers

7) By Hormones: Insulin, Thyroid Hormones, Growth Hormones, Adrenaline

8) By Other Products: Peptides, Serum Proteins, Antigen-Binding Proteins

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=15917&type=smp

Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of theResearch-Grade Proteins Market?# Market?

North America was the largest region in the research-grade proteins market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the research-grade proteins market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Browse Through More Reports Similar to the Global Research-Grade Proteins Market 2025, By The Business Research Company:

Textured Pea Protein Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/textured-pea-protein-global-market-report

Textured Soy Protein Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/textured-soy-protein-global-market-report

C-Reactive Protein Testing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/c-reactive-protein-testing-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

How has the research-grade proteins market grown over the years?

The market size of research-grade proteins has seen a significant expansion in recent years. Its growth is projected to increase from $1.11 billion in 2024 to $1.35 billion in 2025, with a compound annual growth rate (CAGR) of 21.4%. Factors contributing to this growth during the historic period include the escalation of research activities, an upward trend in R&D endeavors in the pharmaceutical and biotechnology sectors, growing interest in personalized medicine, amplified government and academic institute investments, and judicious acquisitions and partnerships.

What Is the forecasted market size and growth rate for the research-grade proteins market?

The research-grade proteins market size is expected to see exponential growth in the next few years. It will grow to $2.9 billion in 2029 at a compound annual growth rate (CAGR) of 21.2%. The growth in the forecast period can be attributed to advancements in proteomics research, growing number of clinical trials, integration of AI and data analytics, use of research-grade proteins in industrial applications and rising demand for advanced research tools. Major trends in the forecast period include growing awareness of innovative technologies, technological advancements in the biotechnology industry, advancements in proteomics and genomics, expanding applications in drug development and advanced research tools in the fields of biotechnology and pharmaceuticals.

Get your research-grade proteins market report here!

https://www.thebusinessresearchcompany.com/report/research-grade-proteins-global-market-report

What are the major factors driving growth in the research-grade proteins market?

The surge in clinical trials is anticipated to fuel the expansion of the research-grade proteins market. Clinical trials, which are research studies that explore the safety and efficacy of novel medical treatments, interventions, or devices in humans, are on the increase due to advancements in medical research, disease prevalence, regulatory shifts, patient needs, and industry investment. Research-grade proteins contribute to clinical trials as crucial components for the development of biomarkers, the creation of assays, the identification of drug targets, quality management, and reference standards, ensuring experimental data’s accuracy and dependability. For example, ClinicalTrials.gov, a clinical trial registry based in the United States, reported that by the end of 2023, the number of registered clinical trials worldwide on ClinicalTrials.gov was 477,234, a rise from the 437,512 clinical trials registered in 2022. Therefore, the escalating number of clinical trials is propelling the growth of the research-grade proteins market.

What key areas define the segmentation of the global research-grade proteins Market?

The research-grade proteins market covered in this report is segmented –

1) By Product: Cytokines And Growth Factors, Antibodies, Immune Checkpoint Proteins, Virus Antigens, Enzymes, Recombinant Regulatory Proteins, Hormones, Other Products

2) By Host Cell: Mammalian Cells, Bacterial Cells, Fungi And Yeast, Insect Cells, Other Host Cells

3) By End-Use: Pharmaceutical And Biotechnology Companies, Academic And Research Institute, Other End-Uses

Subsegments:

1) By Cytokines And Growth Factors: Interleukins, Interferons, Colony Stimulating Factors, Erythropoietin, Granulocyte Macrophage Colony-Stimulating Factor

2) By Antibodies: Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies, Conjugated Antibodies

3) By Immune Checkpoint Proteins: PD-1 Inhibitors, PD-L1 Inhibitors, CTLA-4 Inhibitors

4) By Virus Antigens: HIV Antigens, Hepatitis Antigens, Influenza Antigens, Hepatitis B Antigens

5) By Enzymes: Restriction Enzymes, Proteases, Ligases, Kinases

6) By Recombinant Regulatory Proteins: Transcription Factors, Regulatory Enzymes, Epigenetic Modifiers

7) By Hormones: Insulin, Thyroid Hormones, Growth Hormones, Adrenaline

8) By Other Products: Peptides, Serum Proteins, Antigen-Binding Proteins

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15917&type=smp

Who are the key firms paving the way for growth in the research-grade proteins market?

Major companies operating in the research-grade proteins market are Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Bio-Techne, Stemcell Technologies Inc., Miltenyi Biotec, GenScript Biotech Corporation, Sino Biological Inc., ACROBiosystems, OriGene Technologies Inc., RayBiotech Inc., Rockland Immunochemicals Inc., Proteintech Group Inc., Novus Biologicals LLC, Active Motif, Aviva Systems Biology Corporation, StressMarq Biosciences Inc., Abnova Corporation, AnaSpec, Biomatik, Prospec-Tany Technogene Ltd., Cusabio Technology LLC, United States Biological, Laurus Bio, Boster Biological Technology, AMS Biotechnology Europe Ltd (AMSBIO)

What are the key trends shaping the future of the research-grade proteins market?

Major businesses in the research-grade proteins industry are innovating by creating Cas9 proteins, which have broad applications in biotechnology, particularly in genome editing. Cas9 proteins perform the function of molecular scissors which can slice DNA at particular points as guided by a guide RNA (gRNA). For example, in April 2022, the American biotechnology firm Thermo Fisher Scientific Inc. launched an advanced GMP-produced Gibco CTS TrueCut Cas9 Protein. This top-tier, clinically compatible Cas9 protein is manufactured under Good Manufacturing Practice (GMP) guidelines. It is bespoke designed for genome editing applications and provides high purity and functionality, specifically intended for precise CRISPR-based research. This product will help bring progress in genetic engineering and the development of therapeutics.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15917

Which regions are emerging as leaders in the research-grade proteins market?

North America was the largest region in the research-grade proteins market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the research-grade proteins market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Browse Through More Similar Reports By The Business Research Company:

Textured Pea Protein Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/textured-pea-protein-global-market-report

Textured Soy Protein Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/textured-soy-protein-global-market-report

C-Reactive Protein Testing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/c-reactive-protein-testing-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What is the Predicted Annual Growth Rate of the Research-Grade Proteins Market Over the Coming Decade?

In recent years, the market size for research-grade proteins has experienced rapid growth, with projections forecasting an increase from $1.11 billion in 2024 to $1.35 billion in 2025. This indicates a compound annual growth rate (CAGR) of 21.4%. The expansion in the historical phase can be ascribed to ongoing growth in research endeavors, an uptick in research and development activities within pharmaceutical and biotech industries, increasing interest in personalized medicines, heightened government and academic investment, as well as targeted acquisitions and partnerships.

The market size for research-grade proteins is projected to experience massive growth in the ensuing years, potentially reaching a valuation of $2.9 billion by 2029, increasing at a compound annual growth rate (CAGR) of 21.2%. This surge during the forecast period can be accredited to advancements in proteomics research, the increasing number of clinical trials, the melding of AI and data analytics, usage of research-grade proteins in industrial functions, and the heightening demand for superior research mechanisms. Key trends in the forecast timeframe include the escalating awareness of ground-breaking technologies, technological enhancements in the biotechnology sector, advancements in genomics and proteomics, broadening application in drug advancement, and the evolution of research utilities in the biotech and pharmaceutical realms.

What Factors Are Propelling the Growth of the Research-Grade Proteins Market from 2025 to 2034?

The rise in the number of clinical trials is anticipated to fuel the expansion of the market for research-grade proteins. Clinical trials are research studies that evaluate the safety and efficacy of novel medical treatments, interventions, or devices on humans. Factors such as advancements in medical research, disease burden, regulatory changes, patient demand, and industry investment are leading to an increase in the number of these trials. Research-grade proteins play a crucial role in clinical trials as they serve as crucial resources for the development of biomarkers, assay development, identification of drug targets, quality control, and reference standards, which ensure the precision and dependability of experimental data. For example, data from ClinicalTrials.gov, a US clinical trial registry, showed that by the end of 2023, there were 477,234 clinical trials registered globally, an uptick compared to the 437,512 trials recorded in 2022. As a result, the surge in the number of clinical trials is propelling the expansion of the research-grade proteins market.

Get Your Free Sample of the Global Research-Grade Proteins Market Report Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=15917&type=smp

What Are the Major Players Making an Impact in the Research-Grade Proteins Market’s Growth?

Major companies operating in the research-grade proteins market are:

• Thermo Fisher Scientific Inc.

• Bio-Rad Laboratories Inc.

• Bio-Techne

• Stemcell Technologies Inc.

• Miltenyi Biotec

Which Upcoming Trends Are Set to Influence the Research-Grade Proteins Market’s Path Forward?

Key companies participating in the research-grade proteins industry are advancing their offering by developing Cas9 proteins, that proves pivotal for genome editing and a range of biotechnological applications. By acting as molecular scissors, Cas9 proteins can cut DNA at specific location identified by guide RNA (gRNA), thereby enhancing genome editing. In a recent development, Thermo Fisher Scientific Inc., a U.S. based biotech firm, in April 2022, has rolled out an advanced GMP-produced Gibco CTS TrueCut Cas9 Protein. Characterized by high-quality, clinical compliance and creation under Good Manufacturing Practice (GMP) conditions, this product is catered for genome editing operations. It provides high purity and versatility specifically designed for precise CRISPR-based research, paving the way for further innovation in genetic engineering and therapeutic evolution.

Get Instant Access to the Global Research-Grade Proteins Market Report with Swift Delivery!

https://www.thebusinessresearchcompany.com/report/research-grade-proteins-global-market-report

How Are Key Segments Defining the Competitive Landscape of the Research-Grade Proteins Market?

The research-grade proteins market covered in this report is segmented –

1) By Product: Cytokines And Growth Factors, Antibodies, Immune Checkpoint Proteins, Virus Antigens, Enzymes, Recombinant Regulatory Proteins, Hormones, Other Products

2) By Host Cell: Mammalian Cells, Bacterial Cells, Fungi And Yeast, Insect Cells, Other Host Cells

3) By End-Use: Pharmaceutical And Biotechnology Companies, Academic And Research Institute, Other End-Uses

Subsegments:

1) By Cytokines And Growth Factors: Interleukins, Interferons, Colony Stimulating Factors, Erythropoietin, Granulocyte Macrophage Colony-Stimulating Factor

2) By Antibodies: Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies, Conjugated Antibodies

3) By Immune Checkpoint Proteins: PD-1 Inhibitors, PD-L1 Inhibitors, CTLA-4 Inhibitors

4) By Virus Antigens: HIV Antigens, Hepatitis Antigens, Influenza Antigens, Hepatitis B Antigens

5) By Enzymes: Restriction Enzymes, Proteases, Ligases, Kinases

6) By Recombinant Regulatory Proteins: Transcription Factors, Regulatory Enzymes, Epigenetic Modifiers

7) By Hormones: Insulin, Thyroid Hormones, Growth Hormones, Adrenaline

8) By Other Products: Peptides, Serum Proteins, Antigen-Binding Proteins

What Regions Are Steering Growth in the Research-Grade Proteins Sector?

North America was the largest region in the research-grade proteins market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the research-grade proteins market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

How Can We Define the Research-Grade Proteins Market and Its Key Components?

Research-grade proteins refer to proteins that are produced and purified to a high standard of quality and purity for use in scientific research. These proteins are utilized in various experimental and analytical applications, including studies in molecular biology, biochemistry, cell biology, and drug development. They are essential tools for understanding protein function, interaction, structure, and for developing new therapeutic approaches.

Browse Through More Similar Reports By The Business Research Company:

Textured Pea Protein Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/textured-pea-protein-global-market-report

Textured Soy Protein Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/textured-soy-protein-global-market-report

C-Reactive Protein Testing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/c-reactive-protein-testing-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: